オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

straumann pty ltd - 12143 - tray, instrument - this is a flat shallow vessel that is intended to be used to contain surgical instruments and items.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

straumann pty ltd - 44880 - dental implant suprastructure device, temporary - this is a prefabricated device. scanbodies that are intended to be used to create the necessary suprastructure mimicking preparations of natural teeth as a single use device during dental implant procedures in the mouth.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

straumann pty ltd - 44880 - dental implant suprastructure device, temporary - this is a sterile prefabricated device that is an abutment /scan body that is intended to be used in the mouth to create the necessary suprastructure mimicking preparations of natural teeth. it is used during dental implant restorative and laboratory and or surgery procedures to provide a base (the intermediate fixture level) for a temporary restoration during the healing and sculpturing period of the soft tissue prior to the fabrication and installation of the final restoration.

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

european regulatory affairs t/a ivowen - bimatoprost - eye drops, solution - 0.3 milligram(s)/millilitre - bimatoprost

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

straumann pty ltd - 45714 - fixture/appliance dental drill, reusable - this is a metal shaft in the form of a drill bit that is intended to be used in dental surgery in the mouth to create channels (bore hole) that is of appropriate depth and diameter in bone (osteotomy) of the oral cavity to facilitate the implantation of a dental fixture/appliance.

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

bausch + lomb ireland limited - dorzolamide - eye drops, solution - 20 milligram(s)/millilitre - carbonic anhydrase inhibitors; dorzolamide

ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - dorzolamide hydrochloride 22.26 mg/ml equivalent to 20 mg/ml dorzolamide; timolol maleate 6.83 mg/ml equivalent to 5 mg/ml timolol - eye drops, solution - active: dorzolamide hydrochloride 22.26 mg/ml equivalent to 20 mg/ml dorzolamide timolol maleate 6.83 mg/ml equivalent to 5 mg/ml timolol excipient: hyetellose mannitol sodium citrate dihydrate sodium hydroxide water for injection - indicated in the treatment of elevated intraocular pressure (iop) in patients with: · ocular hypertension · open-angle glaucoma · pseudoexfoliative glaucoma · or other secondary open-angle glaucoma's and who are: · insufficiently responsive to topical beta blocker monotherapy · currently receiving concomitant antiglaucoma therapies such as dorzolamide hydrochloride and timolol maleate.

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

morningside healthcare (malta) limited - bimatoprost - eye drops, solution - bimatoprost

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

bio balance australia pty ltd - ascorbic acid, quantity: 20 mg; d-alpha-tocopheryl acetate, quantity: 7.5 mg; thiamine hydrochloride, quantity: 10 mg (equivalent: thiamine, qty 7.87 mg); riboflavin, quantity: 1 mg; nicotinamide, quantity: 5 mg; pyridoxine hydrochloride, quantity: 5 mg (equivalent: pyridoxine, qty 4.11 mg); calcium pantothenate, quantity: 5.46 mg (equivalent: pantothenic acid, qty 5 mg); magnesium citrate, quantity: 95.54 mg (equivalent: magnesium, qty 15 mg); zinc citrate dihydrate, quantity: 19.17 mg (equivalent: zinc, qty 6 mg); copper gluconate, quantity: 10.71 mg (equivalent: copper, qty 1.5 mg); manganese sulfate monohydrate, quantity: 2 mg (equivalent: manganese, qty 0.65 mg); chromium picolinate, quantity: 48.27 microgram (equivalent: chromium, qty 6 microgram); silybum marianum, quantity: 60 mg (equivalent: silybum marianum, qty 4.2 g); zingiber officinale, quantity: 50 mg (equivalent: zingiber officinale, qty 1 g); panax ginseng, quantity: 50 mg (equivalent: panax ginseng, qty 0.5 g); piper nigrum, quantity: 0.3704 mg (equivalent: piper nigrum, qty 20 mg); hovenia dulcis, quantity: 300 mg (equivalent: hovenia dulcis, qty 6 g); opuntia ficus-indica, quantity: 30 mg (equivalent: opuntia ficus-indica, qty 0.3 g); pueraria lobata, quantity: 30 mg (equivalent: pueraria lobata, qty 1.5 g); colecalciferol, quantity: 0.0125 mg - capsule, hard - excipient ingredients: maltodextrin; microcrystalline cellulose; silicon dioxide; magnesium stearate; calcium hydrogen phosphate dihydrate; hypromellose; modified food starch; maize starch; acacia; dl-alpha-tocopherol; sucrose; medium chain triglycerides - maintain/support energy levels ; maintain/support energy production ; traditionally used in chinese medicine to relieve weariness/tiredness/fatigue/feeling of weakness ; maintain/support general health and wellbeing ; traditionally used in chinese medicine to helps decrease/reduce/relieve symptoms of occasional hangovers ; maintain/support mental concentration/focus/clarity ; maintain/support cognitive function/mental function

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

stada pharmaceuticals australia pty ltd - 35419 - tube, feeding, gastrostomy - provide access for lecigon peg j for long-term channelling of medication lecigon to the small intestine when use in conjunction with the lecigon peg j, intestinal tube. enteral nutrition may be channelled directly to the stomach in parallel with medication delivery to the intesting.